Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System.
Soo Jie ChungSun-Ju ByeonJeong Hee ChoiPublished in: Journal of Korean medical science (2022)
Our data are clinically informative for recognizing and coping with ADRs of anti-TB drugs.